Recent Updates
Recently added Catalysts
Avidity Partners
Track Avidity Partners's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Sep 18, 2026
Showing 6 Stocks Out Of 38. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 SCYX | SCYNEXIS INC | 260.21 K | 1.06 M | 0.2 | |
 CRL | CHARLES RIV LABS INTL INC | 10.00 K | 2.27 M | 0.4 | |
 ORKA | ORUKA THERAPEUTICS INC | 760.42 K | 72.37 M | 11.6 | |
 NVCT | NUVECTIS PHARMA INC | 200.00 K | 3.68 M | 0.6 | |
 RGEN | REPLIGEN CORP | 77.80 K | 10.62 M | 1.7 | |
 DXCM | DEXCOM INC | 100.00 K | 6.74 M | 1.1 |
Market Value
$ 578.10 M
Holdings
38
Period
Q2 2026
Holdings in Top 20
%
QoQ Changes
41.31 %